International Clinical Trial: Intra-Articular Ozone (O3) Injection Combined with Platelet-Rich Plasma (PRP) for Knee Meniscal Injury: A Randomized Controlled Trial

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121999) titled 'Intra-Articular Ozone (O3) Injection Combined with Platelet-Rich Plasma (PRP) for Knee Meniscal Injury: A Randomized Controlled Trial' on April 8.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Mianyang 404 Hospital

Condition: Knee Meniscal Injury

Intervention: Intervention group:Intra-articular injection of ozone (O?) combined with platelet-rich plasma (PRP) into the knee joint, administered once every 3 weeks for a total of three injections, with an intervention period of 9 weeks.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-15

Target S...